Photodynamic Effects of Zinc(II) Phthalocyanine‐Loaded Polymeric Micelles in Human Nasopharynx KB Carcinoma Cells

Photochemistry and Photobiology - Tập 89 Số 2 - Trang 492-500 - 2013
María C. García Vior1, Julieta Marino2, Leonor P. Roguin2, Alejandro Sosnik3, Josefina Awruch1
1Departamento de Química Orgánica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
2Instituto de Química y Fisicoquímica Biológicas (UBA‐CONICET) Facultad de Farmacia y Bioquímica Buenos Aires Argentina
3BIONIMED Departamento de Tecnología Farmacéutica Facultad de Farmacia y Bioquímica Buenos Aires Argentina

Tóm tắt

Abstract

A major difficulty in photodynamic therapy is the poor solubility of the photosensitizer (PS) under physiological conditions which correlates with low bioavailability. PS aggregation leads to a decrease in the photodynamic efficiency and a more limited activity in vitro and in vivo. To improve the aqueous solubility and reduce the aggregation of 2,9(10),16(17),23(24)‐tetrakis[(2‐dimethylamino)ethylsulfanyl]phthal‐ocyaninatozinc(II) (Pc9), the encapsulation into four poloxamine polymeric micelles (T304, T904, T1107 and T1307) displaying a broad spectrum of molecular weight and hydrophilic–lipophilic balance was investigated. The aqueous solubility of Pc9 was increased up to 30 times. Morphological evaluation showed the formation of Pc9‐loaded spherical micelles in the nanosize range. UV/Vis and fluorescence studies indicated that Pc9 is less aggregated upon encapsulation in comparison with Pc9 in water–DMSO 2% and remained photostable. Pc9‐loaded micelles generated singlet molecular oxygen in high yields. Photocytotoxicity assays using human nasopharynx KB carcinoma cells confirmed that the encapsulation of Pc9 in T1107 and T1307 increases its photocytotoxicity by 10 times in comparison with the free form in water–DMSO. In addition, Pc9 incorporated into cells was mainly localized in lysosomes.

Từ khóa


Tài liệu tham khảo

10.1093/jnci/90.12.889

10.1021/jm040074b

10.1016/S1011-1344(97)00128-0

10.1002/(SICI)1096-9101(2000)26:3<308::AID-LSM9>3.0.CO;2-B

10.1016/S1011-1344(96)07370-8

Stockert J. C., 2004, Photodynamic therapy: Selective uptake of photosensitizing drugs into tumor cells, Curr. Top. Pharmacol., 8, 185

Szeimies R. M., 2005, Photodynamic therapy for nonmelanoma skin cancer, Acta Derm.Venereol., 8548, 3

Fabris C., 2001, Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis an necrosis, Cancer Res., 15, 7495

10.1021/cr980439y

10.1038/bjp.2008.98

10.1016/j.biocel.2008.02.024

10.2174/092986707780830970

10.1039/b802709a

10.1016/j.ejmech.2010.06.002

10.1016/j.ejmech.2011.09.014

10.1039/b303428n

10.1016/S1011-1344(01)00267-6

Lipinski C., 2002, Poor aqueous solubility: An industry wide problem in drug delivery, Am. Pharm. Rev., 5, 82

10.1142/S1088424606000053

10.1016/j.addr.2006.09.009

10.1002/jps.22007

10.1016/j.dyepig.2011.03.011

10.1016/j.jconrel.2007.09.002

10.1016/j.ejpb.2007.03.022

10.2174/1874764710801010043

10.1023/B:PHAM.0000016235.32639.23

10.1023/A:1010618632738

10.1021/la8016563

10.2217/nnm.10.53

10.1111/j.1751-1097.1996.tb09631.x

10.1111/j.1751-1097.1978.tb06972.x

10.1063/1.555965

10.1002/(SICI)1099-1409(199704)1:2<159::AID-JPP19>3.0.CO;2-8

10.1142/S1088424602000166

10.1039/b815726j

10.1016/0022-1759(83)90303-4

10.1016/j.ejpb.2007.11.021

10.1208/s12249-008-9070-8

10.2217/nnm.09.90

10.1016/j.biomaterials.2010.11.082

10.1016/j.ejpb.2010.05.007

10.1016/j.jphotobiol.2006.01.011

10.1021/jp0768423

10.1142/S1088424610002008

10.1111/j.1751-1097.1991.tb02071.x

10.1016/j.nano.2011.01.017

10.2741/e102

10.1021/mp2000132